Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu
Secondary Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: Mycosis Study Group

Inconclusive Data in IA: Experts Fill the Void To Avoid Horror Vacui

Posted on November 14, 2016 by Harald — No Comments ↓

Often we come across a study which raises more questions than it answers.  Sometimes we read a study publication again and again, and still we cannot figure out what the take-away learning is, as results are simply inconclusive or discordant. Continue reading Inconclusive Data in IA: Experts Fill the Void To Avoid Horror Vacui→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email

Like this:

Like Loading...
Posted in Recent Literature, The Viewpoint | Tagged anidulafungin, aspergillosis therapy, combination antifungal therapy, echinocandin, Eraxis, galactomannan, Harald Reinhart, invasive aspergillosis, MSG, Mycosis Study Group, Pfizer, publication bias, RCT, subset analyses, Vfend, Voriconazole | Leave a reply

Primary Sidebar Widget Area

Posts and Blogs

  • About A Prepared Mind – In R&D
  • The 10 x ’20 Initiative – A Retrospective
  • BAFF / APRIL Inhibitors Homing in on IgAN
  • THE UTILITY OF FUTILITY
  • Sulopenem uUTI – Does It Suffice?
  • PUBLICATION OVERACHIEVERS
  • BLUJEPA / Gepotidacin APPROVED FOR UNCOMPLICATED UTI – 1
  • Gepotidacin ABSSSI – How to Fail Adaptively
  • A Critical Review of WHO’s List of Antibacterials in Clinical Development
  • Some Thoughts about the New Coronavirus Syndrome and its Transmission

Subscribe to AllphasePharma Blogs via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Tags

ABSSSI Achaogen Allphase Pharma Consulting aminoglycoside antibiotic blog Avelox Bayer Ceftazidime/avibactam cIAI ciprofloxacin colistin Cubicin Cubist cUTI dalbavancin Dalvance daptomycin delafloxacin eravacycline FDA fosfomycin GSK Harald Reinhart levofloxacin Merck meropenem moxifloxacin MRSA Novartis omadacycline Orbactiv oritavancin P. aeruginosa Pfizer PK/PD plazomicin QIDP solithromycin tedizolid tetracycline Tetraphase tigecycline Tygacil vancomycin VAP

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2025 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d